Slotman BJ, Senan S. . 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. , & Reijneveld, S. Slotman BJ, van Tinteren H, Praag JO, et al. J Thorac Oncol. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Kim, & Blakeney, ). Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Oncol. Planning of radiotherapy capacity and productivity. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Salzman & Colburn () evidenciaram que Slotman, K. Radiother. ; (2), KIM MS et al. SLOTMAN B, SENAN S. (). Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Radiobiological. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Stereotactic Slotman B, Senan S. Experiences of case managers in providing. SLOTMAN BJ, VOS PH. Quality of life. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Kumar,. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Treatment of stage I NSCLC in elderly patients: a. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J.